Zydus Lifesciences Ltd. - Research Center
532321 ZYDUSLIFE Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Sales | 2,515.90 | 2,620.60 | 4,160.20 | 3,332.40 | 2,371.30 |
| Operating profit | 648.50 | 942.20 | 2,372.90 | 1,569.20 | 699.10 |
| Interest | 97.20 | 95.90 | 115.40 | 106.20 | 103.90 |
| Gross profit | 628.80 | 1,173.00 | 2,364.10 | 1,824.10 | 702.00 |
| EPS (Rs) | 4.68 | 7.85 | 16.91 | 13.97 | 4.45 |
Quarterly
results in details
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Other income | 77.50 | 326.70 | 106.60 | 361.10 | 106.80 |
| Stock adjustment | 187.80 | -138.90 | -46.40 | -86.20 | 24.50 |
| Raw material | 635.80 | 704.80 | 725.70 | 737.20 | 681.60 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 425.00 | 436.50 | 424.40 | 405.10 | 373.00 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 618.80 | 676.00 | 683.60 | 707.10 | 593.10 |
| Provisions made | - | - | - | - | - |
| Depreciation | 131.60 | 133.70 | 130.60 | 130.60 | 127.70 |
| Taxation | 26.60 | 249.50 | 532.70 | 279.70 | 123.90 |
| Net profit / loss | 470.60 | 789.80 | 1,700.80 | 1,405.20 | 450.40 |
| Extra ordinary item | - | - | - | -8.60 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 100.60 | 100.60 | 100.60 | 100.60 | 101.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 25.78 | 35.95 | 57.04 | 47.09 | 29.48 |
| GPM (%) | 24.25 | 39.80 | 55.41 | 49.39 | 28.33 |
| NPM (%) | 18.15 | 26.80 | 39.86 | 38.05 | 18.18 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis